Last reviewed · How we verify
NCT05637385
Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus
NA trial testing Training of perception and oculo-motor control in Central Visual Impairment in 24 participants. Status unknown.
1 October 2024
Quick facts
| Lead sponsor | Russell L. Woods |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 March 2023 |
| Primary completion | 1 October 2024 |
| Estimated completion | 1 October 2024 |
Drugs / interventions tested
- Training of perception and oculo-motor control
Conditions studied
- Central Visual Impairment — all drugs for Central Visual Impairment →
Sponsor
Russell L. Woods
Who can join
18 and older, any sex, with Central Visual Impairment. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
When high-detail vision is lost due to a retinal disease such as macular degeneration, people see poorly, and have difficulty with eye movements (oculo-motor control). This preliminary study will investigate a potential behavioral intervention that may improve the ability to perform vision-related daily activities such as reading, recognising faces and watching television. The intervention involves many sessions that will train visual perception and eye movements over a period of a few months. Participants will have either lost central vision in both eyes or have normal vision (control group).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05637385
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05637385 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Russell L. Woods
- Last refreshed: 5 December 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05637385.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing